Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma

Clinical trial NCT00667420 · TERMINATED

Trial details

NCT number: NCT00667420
Sponsor: Massachusetts General Hospital
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Esophageal Adenocarcinoma Gastric Adenocarcinoma

Start date: 2008-04-01
Primary completion: 2011-06-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.